By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kamada Ltd. 

Kibbutz Beit Kama M.P.

Negev    85325  Israel
Phone: 07-991-2082 Fax: 07-991-2083




Company News
Kamada Ltd. (KMDA) Announces Positive Interim Results From Phase 1/2 Clinical Study Of Its Human Alpha-1 Antitrypsin To Treat Graft-Versus-Host Disease Presented At American Society of Hematology Annual Meeting 12/11/2014 7:21:59 AM
Kamada Ltd. (KMDA) Announces Third Quarter 2014 Financial Results 11/12/2014 9:51:20 AM
Kamada Ltd. (KMDA) To Host Third Quarter 2014 Financial Results Conference Call On November 12, 2014 11/10/2014 10:13:57 AM
FDA Grants Kamada Ltd. (KMDA) Orphan Drug Designation For The Treatment Of Graft Versus Host Disease 10/29/2014 8:39:28 AM
Kamada Ltd. (KMDA) Announces Study In Support Of Alpha-1 Antitrypsin For The Treatment Of Type-1 Diabetes Published In The Journal Of Diabetes Science And Technology 10/21/2014 11:06:15 AM
Kamada Ltd. (KMDA) Extends Glassia Agreement With Baxter International, Inc. (BAX) 9/29/2014 6:31:15 AM
Kamada Ltd. (KMDA) Reports Final Results From Phase 2/3 Clinical Trial Of Inhaled Alpha-1 Antitrypsin To Treat Alpha-1 Antitrypsin Deficiency 9/4/2014 11:38:00 AM
Kamada Ltd. (KMDA) Reports Second Quarter Financial Results 8/14/2014 8:10:08 AM
Kamada Ltd. (KMDA) To Host Second Quarter Financial Results Conference Call On Thursday, August 14, 2014 8/6/2014 9:27:49 AM
Kamada Ltd. (KMDA) Crashes After Key Trial Failure 5/16/2014 7:57:40 AM